Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wentian Guo

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Biopharmaceutical Statistics|February 13, 2019
R-TPI: rolling toxicity probability interval design to shorten the duration and maintain safety of phase I trialsWentian Guo, Yuan Ji, Daniel Li
Statistics in Biosciences|November 4, 2015
TEAMS: Toxicity- and Efficacy-based Dose Insertion Design with Adaptive Model Selection for Phase I/II Dose-Escalation Trials in OncologyWentian Guo, Yang Ni, Yuan Ji
JCO Precision Oncology|September 14, 2020
Bayesian Approaches to Subgroup Analysis and Related Adaptive Clinical Trial DesignsCiara Nugent, Wentian Guo, Peter Müller, et al.
Biometrics|October 25, 2016
A subgroup cluster-based Bayesian adaptive design for precision medicineWentian Guo, Yuan Ji, Daniel V T Catenacci
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 16, 2016
Toxicity and Efficacy Probability Interval Design for Phase I Adoptive Cell Therapy Dose-Finding Clinical TrialsDaniel H Li, James B Whitmore, Wentian Guo, et al.
Contemporary Clinical Trials|May 2, 2017
A Bayesian interval dose-finding design addressingOckham's razor: mTPI-2Wentian Guo, Sue-Jane Wang, Shengjie Yang, et al.
Scientific Reports|December 8, 2015
Deciphering Genomic Underpinnings of Quantitative MRI-based Radiomic Phenotypes of Invasive Breast CarcinomaYitan Zhu, Hui Li, Wentian Guo, et al.
Journal of Parkinson'S Disease|May 3, 2021
Plasma Short-Chain Fatty Acids Differences in Multiple System Atrophy from Parkinson's DiseaseXiaoqin He, Yiwei Qian, Shaoqing Xu, et al.
Journal of Medical Imaging (Bellingham, Wash.)|February 3, 2016
Prediction of clinical phenotypes in invasive breast carcinomas from the integration of radiomics and genomics dataWentian Guo, Hui Li, Yitan Zhu, et al.
Nature Communications|April 5, 2022
Neutralizing activity of BBIBP-CorV vaccine-elicited sera against Beta, Delta and other SARS-CoV-2 variants of concernXiaoqi Yu, Dong Wei, Wenxin Xu, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Biopharmaceutical Statistics|February 13, 2019
R-TPI: rolling toxicity probability interval design to shorten the duration and maintain safety of phase I trialsWentian Guo, Yuan Ji, Daniel Li
Statistics in Biosciences|November 4, 2015
TEAMS: Toxicity- and Efficacy-based Dose Insertion Design with Adaptive Model Selection for Phase I/II Dose-Escalation Trials in OncologyWentian Guo, Yang Ni, Yuan Ji
JCO Precision Oncology|September 14, 2020
Bayesian Approaches to Subgroup Analysis and Related Adaptive Clinical Trial DesignsCiara Nugent, Wentian Guo, Peter Müller, et al.
Biometrics|October 25, 2016
A subgroup cluster-based Bayesian adaptive design for precision medicineWentian Guo, Yuan Ji, Daniel V T Catenacci
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 16, 2016
Toxicity and Efficacy Probability Interval Design for Phase I Adoptive Cell Therapy Dose-Finding Clinical TrialsDaniel H Li, James B Whitmore, Wentian Guo, et al.
Contemporary Clinical Trials|May 2, 2017
A Bayesian interval dose-finding design addressingOckham's razor: mTPI-2Wentian Guo, Sue-Jane Wang, Shengjie Yang, et al.
Scientific Reports|December 8, 2015
Deciphering Genomic Underpinnings of Quantitative MRI-based Radiomic Phenotypes of Invasive Breast CarcinomaYitan Zhu, Hui Li, Wentian Guo, et al.
Journal of Parkinson'S Disease|May 3, 2021
Plasma Short-Chain Fatty Acids Differences in Multiple System Atrophy from Parkinson's DiseaseXiaoqin He, Yiwei Qian, Shaoqing Xu, et al.
Journal of Medical Imaging (Bellingham, Wash.)|February 3, 2016
Prediction of clinical phenotypes in invasive breast carcinomas from the integration of radiomics and genomics dataWentian Guo, Hui Li, Yitan Zhu, et al.
Nature Communications|April 5, 2022
Neutralizing activity of BBIBP-CorV vaccine-elicited sera against Beta, Delta and other SARS-CoV-2 variants of concernXiaoqi Yu, Dong Wei, Wenxin Xu, et al.
Pageof 2